Biologics · For physicians
How to Combine Shockwave Therapy and PRP for Tendinopathy
Published November 15, 2026
- Mechanism Synergy
- Mechanical + Biological
- Typical ESWT Cadence
- Multi-Session Series
- Cost Structure
- Capital + Consumable
ESWT provides acoustic mechanotransduction while PRP supplies concentrated autologous growth factors.
Shockwave is commonly delivered across a series of weekly intervals, whereas PRP is often a single or staged injection.
Combined protocols blend fixed device amortization (shockwave) with per-case disposable kit costs (PRP).
To combine shockwave therapy and PRP for tendinopathy, clinicians typically sequence extracorporeal shockwave therapy (ESWT) either before a platelet-rich plasma injection to prime the local tissue environment via mechanotransduction, or in the subacute phase following PRP to support extracellular matrix remodeling. Both modalities target failed healing responses in degenerated tendon tissue, with ESWT delivering acoustic mechanical stimuli and PRP providing concentrated autologous growth factors. The exact sequencing, energy flux density, and leukocyte concentration depend on the specific tendon pathology, chronicity, and the treating physician's clinical judgment.
Physiological Rationale for Dual-Modality Tendon Treatment
Chronic tendinopathy is primarily a degenerative condition characterized by disorganized collagen fibers, mucoid degeneration, neovascularization, and a relative absence of acute inflammatory cells. Because the pathology represents a stalled healing cascade rather than simple inflammation, monotherapies that only suppress pain often fail to restore structural integrity.
Combining regenerative devices and biologics addresses tendon pathology through two distinct yet complementary pathways:
- Extracorporeal Shockwave Therapy (ESWT): Acoustic waves generate mechanical stress and micro-cavitation within the tendon matrix. Through mechanotransduction, this physical stimulus promotes neovascularization, modulates local pain pathways (via hyperstimulation analgesia and substance P depletion), and upregulates endogenous expression of tenocyte proliferation signals.
- Platelet-Rich Plasma (PRP): Autologous platelet concentrates deliver a supraphysiological bolus of signaling proteins—including PDGF, TGF-beta, and VEGF—directly to the hypovascular tendon core. These cytokines recruit reparative cells, stimulate tenocyte proliferation, and guide the synthesis of type I collagen.
When deployed together in orthopedics and sports medicine, ESWT acts as the mechanical catalyst that prepares or remodels the tissue bed, while PRP supplies the concentrated biological building blocks required for cellular repair.
Clinical Sequencing Models: How to Structure the Protocol
When evaluating how to combine shockwave therapy and PRP for tendinopathy, physicians generally choose from three clinical sequencing models. Because standardized consensus guidelines vary by anatomical site, the treating clinician must tailor the protocol to ultrasound findings, calcific burden, and patient activity levels.
1. Pre-Conditioning (ESWT Followed by PRP)
In this approach, the patient undergoes a short series of ESWT sessions (or a single priming session) prior to the PRP injection. The rationale is to disrupt calcific deposits, break down fibrotic adhesions, and induce local hyperemia before introducing autologous platelets. By increasing vascular permeability and upregulating local growth factor receptors via mechanotransduction, the tissue environment may be more receptive to the subsequent biologic payload.
2. Same-Day Sequential Administration
Some practices perform ESWT immediately prior to the ultrasound-guided PRP injection during a single clinical visit. This model maximizes patient convenience and compliance, particularly for traveling or high-demand patients. Clinicians utilizing this approach typically apply shockwave first to stimulate the tissue and provide brief hyperstimulation analgesia, followed by sterile skin preparation and the targeted PRP injection. Applying high-energy shockwave immediately after a fresh fluid injection into a confined tendon space is generally avoided by many practitioners to prevent mechanical dispersion of the injectate away from the target lesion, though clinical practices vary.
3. Post-PRP Remodeling (PRP Followed by Delayed ESWT)
In this sequence, the physician performs the ultrasound-guided PRP injection first and allows the acute inflammatory and early proliferative phases to proceed undisturbed. Once the initial post-injection soreness subsides—often several weeks post-injection, depending on the clinician's protocol—ESWT is introduced alongside eccentric physical therapy. Here, the acoustic waves guide collagen fiber alignment and support tissue remodeling during the maturation phase.
Clinical Decision Checklist for Protocol Selection
Before initiating a combined protocol, the evaluating physician should review the following clinical parameters:
- Tendon Morphology and Tear Severity: Differentiate between diffuse tendinosis, partial-thickness tearing, and calcific tendinopathy using diagnostic musculoskeletal ultrasound or MRI. High-grade partial tears or complete ruptures may require surgical evaluation rather than conservative shockwave protocols.
- Shockwave Modality Selection: Choose between focused shockwave (fESWT), which concentrates acoustic energy at a specific focal depth for deeper tendons (e.g., proximal hamstring, gluteal tendons), and radial pressure wave (rESWT), which disperses energy more superficially (e.g., Achilles mid-portion, plantar fascia, lateral epicondyle).
- PRP Formulation: Select the appropriate platelet concentration and leukocyte profile. Many sports medicine doctors utilize leukocyte-rich PRP (LR-PRP) for chronic, fibrotic tendinopathies to provoke a controlled inflammatory response, while others prefer leukocyte-poor PRP (LP-PRP) to minimize post-injection flares.
- Medication Washout: Ensure appropriate hold periods for NSAIDs and antiplatelet medications prior to PRP harvesting and injection, in accordance with clinical guidelines and the patient's cardiovascular risk profile.
- Rehabilitation Integration: Coordinate the timeline for eccentric loading and physical therapy so mechanical loading complements rather than disrupts the biological healing phases.
Operational Considerations for Practice Managers
While the physician determines clinical appropriateness, the practice manager must ensure that combining shockwave therapy and PRP is operationally viable and financially sustainable. Dual-modality care tracks require tight coordination between scheduling, inventory management, and billing.
Workflow and Staffing Efficiency
A combined protocol alters room turnover and staff allocation. An ESWT session is relatively quick and, depending on state scope-of-practice laws and device classification,certain components of patient setup may be supported by trained clinical staff under physician supervision. Conversely, a PRP procedure requires phlebotomy, centrifugation processing time, sterile tray setup, ultrasound imaging, and direct physician injection time. Stacking these procedures on the same day requires block scheduling so the exam room is not bottlenecked during the centrifugation spin cycle.
Procurement and Cost-Per-Treatment Tracking
Practice managers must track two distinct cost structures:
- Consumable Biologic Costs: Every PRP treatment consumes a dedicated processing kit, anticoagulant, phlebotomy supplies, and sterile injection consumables.
- Device Amortization and Maintenance: Shockwave systems involve capital equipment depreciation and periodic replacement of handpiece transmitters or shockwave heads based on pulse counts.
Bundling these therapies into a comprehensive tendon recovery package requires transparent cash-pay pricing models, as many commercial payers classify both ESWT and autologous PRP for tendinopathy as non-covered or investigational services. Clear financial counseling and ABN (Advance Beneficiary Notice) workflows are essential prior to initiating care.
What This Means for Your Practice
Integrating shockwave therapy and PRP allows musculoskeletal practices to offer a tiered, comprehensive approach to recalcitrant tendinopathy:
- Audit your current equipment and biologics: Evaluate whether your current centrifuge system produces consistent platelet yields and whether your shockwave device offers the depth penetration required for your patient population.
- Standardize clinical pathways: Establish clear internal guidelines dictating which tendinopathies receive monotherapy versus combined therapy, and document the washout and physical therapy timelines.
- Align operational workflows: Train clinical staff on sterile setup for PRP alongside shockwave room preparation to keep procedure durations predictable.
If your clinic is evaluating regenerative equipment or refining its autologous biologic supply chain, contact Dallas Regenerative Solutions to schedule a consultation with our clinical device and biologics specialists.
Frequently asked questions
- Should shockwave therapy be performed before or after a PRP injection?
- Clinicians utilize both sequences depending on treatment goals. Performing ESWT prior to PRP is often used to prime the tissue environment, stimulate local vascularity, and address calcifications before introducing growth factors. Conversely, introducing ESWT several weeks after a PRP injection is frequently used to support extracellular matrix remodeling and collagen alignment during the subacute healing phase.
- Can ESWT and PRP be administered on the same day?
- Yes, some practices perform ESWT immediately prior to the PRP injection during the same visit to streamline patient scheduling. In this workflow, shockwave is typically applied first to provide mechanical stimulation, followed by sterile prep and the ultrasound-guided PRP injection. Clinicians generally avoid applying high-energy shockwave immediately over a freshly injected tendon to prevent dispersing the biologic fluid.
- What is the difference between focused and radial shockwave when combining with PRP?
- Focused shockwave (fESWT) delivers converging acoustic waves to a precise focal depth, making it suitable for deeper structures like the proximal hamstring or gluteal tendons alongside deep ultrasound-guided PRP injections. Radial pressure waves (rESWT) deliver energy that dissipates from the skin surface outward, which is commonly paired with superficial tendon protocols such as lateral epicondylitis or Achilles tendinopathy.
- How does combining ESWT and PRP affect practice scheduling and room turnover?
- Standalone shockwave sessions require minimal setup and short room blocks, whereas PRP requires blood draw, centrifugation time, and sterile ultrasound-guided injection setup. When combining both modalities in a single care plan, practice managers can optimize room utilization by performing the ESWT session during the PRP centrifugation spin cycle or scheduling the modalities on separate visits.
- Which tendinopathies are commonly evaluated for combined shockwave and PRP protocols?
- Orthopedic and sports medicine practices frequently evaluate chronic, refractory cases of lateral epicondylitis, patellar tendinopathy, mid-portion or insertional Achilles tendinopathy, rotator cuff tendinopathy, and proximal plantar fasciopathy. Final patient selection depends on diagnostic imaging findings, tear severity, and the treating physician's clinical assessment.
